AbbVie: all 2,241 studies
Page 21 of 23. Open to participants first (134), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess Injection Comfort of Two Formulations of ATX-101CompletedNCT01320761Phase 1
- Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat TissueCompletedNCT01319916Phase 1
- Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPITerminatedNCT01313572Phase 3
- Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the HospitalCompletedNCT01298843Phase 4
- Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionWithdrawnNCT01284166Phase 3
- Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract InfectionsCompletedNCT01281462Phase 2
- Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)CompletedNCT01279590Phase 2
- Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic ConjunctivitisCompletedNCT01258309Phase 3
- A Study of ABT-806 in Subjects With Advanced Solid Tumor TypesCompletedNCT01255657Phase 1
- Single IV Dose of GLYX-13 in Patients With Treatment-Resistant DepressionCompletedNCT01234558Phase 2
- Effect of Udenafil on SpermatogenesisCompletedNCT01230541Phase 1
- A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01225302Phase 1
- A Study of ABT-652 in Adults With Osteoarthritis Pain of the KneeCompletedNCT01207115Phase 2
- To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid TumorsCompletedNCT01199224Phase 1
- Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial PneumoniaTerminatedNCT01198626Phase 2
- A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal PainTerminatedNCT01159119Phase 1
- Safety Study of LiRIS in Interstitial Cystitis (IC) PatientsCompletedNCT01150565Phase 1
- A Safety and Tolerability Study of PCI-24781 in Subjects With CancerCompletedNCT01149668Phase 1
- A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary HyperparathyroidismCompletedNCT01149291
- Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in ContraceptionCompletedNCT01140217Phase 3
- Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's DiseaseCompletedNCT01137526Phase 2
- Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal MalesCompletedNCT01133548Phase 1
- An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt BarrierCompletedNCT01130298Phase 1
- Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)CompletedNCT01128530Phase 2
- Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid TumorCompletedNCT01123876Phase 1
- A Study to Assess the Effect of Rifampin on the Metabolism of NavitoclaxCompletedNCT01121133Phase 1
- A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian CancerCompletedNCT01113957Phase 2
- ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid TumorsCompletedNCT01110486Phase 1
- ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic MalignanciesCompletedNCT01110473Phase 1
- Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With SchizophreniaCompletedNCT01095562Phase 2
- A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve PatientsCompletedNCT01092104Phase 1/2
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneTerminatedNCT01089790Phase 3
- A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate CancerCompletedNCT01085422Phase 1
- A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RACompletedNCT01078597
- Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaCompletedNCT01077700Phase 2
- Documentation of Humira in Psoriasis Patients in Routine Clinical PracticeCompletedNCT01077232
- A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic LeiomyomataCompletedNCT01069094Phase 1/2
- Proellex Pharmacokinetics Bridging StudyCompletedNCT01067807Phase 1
- Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary HypogonadismCompletedNCT01067365Phase 3
- Treatment of Erectile Dysfunction - Long Term Safety and EfficacyCompletedNCT01065012Phase 3
- A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid TumorsCompletedNCT01063816Phase 1
- Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)CompletedNCT01036854Phase 1
- Safety Study of F2695 SR in Major Depressive DisorderCompletedNCT01034267Phase 3
- Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's DiseaseCompletedNCT01018875Phase 2
- Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal VolunteersCompletedNCT01014650Phase 1
- A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsCompletedNCT01009073Phase 1
- IMGN901 in Combination With Lenalidomide and DexamethasoneCompletedNCT00991562Phase 1
- Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPITerminatedNCT00990327Phase 3
- Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With AsthmaCompletedNCT00986037Phase 1
- Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With CancerCompletedNCT00982566Phase 1
- Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)CompletedNCT00981487Phase 1
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With PioglitazoneTerminatedNCT00970424Phase 3
- Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary HypogonadismCompletedNCT00962637Phase 3
- Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's DiseaseCompletedNCT00948909Phase 2
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without MetforminTerminatedNCT00947557Phase 3
- Effects of Oxybutynin Topical Gel on Gastric EmptyingCompletedNCT00926926Phase 1
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System InhibitorsCompletedNCT00920764Phase 2
- Bioavailability Study of Anti Nausea Medication With and Without FoodCompletedNCT00905190Phase 1
- Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid TumorsCompletedNCT00891605Phase 1
- A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With SchizophreniaCompletedNCT00888693Phase 1
- Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid TumorsCompletedNCT00887757Phase 1
- Study of Proellex in Pre-menopausal Women With Symptomatic Uterine FibroidsCompletedNCT00882258Phase 2
- Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy FemalesCompletedNCT00881062Phase 1
- A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With CancerCompletedNCT00878449Phase 1
- Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid SymptomsWithdrawnNCT00874302Phase 3
- A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 StudiesCompletedNCT00872196Phase 2
- Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With FoodCompletedNCT00868907Phase 1
- Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00868413Phase 1
- Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1CompletedNCT00850044Phase 1
- Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell LymphomaCompletedNCT00849654Phase 1
- A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female SubjectsCompletedNCT00846196Phase 1
- Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic PainCompletedNCT00838799Phase 2
- Analysis of Iliac Crest Biopsies From Patients Receiving RisedronateCompletedNCT00837746
- ATX-101 AbdominoplastyCompletedNCT00835952Phase 1
- A Natural History Study of Patients With Dry EyeCompletedNCT00833235
- Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00822055Phase 4
- Chronic Plaque Psoriasis (Ps) RegistryCompletedNCT00799877
- Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference PatchCompletedNCT00791856Phase 1
- Safety Study of ABT-263 in Combination With Rituximab in Lymphoid CancersCompletedNCT00788684Phase 1
- Juvenile Idiopathic Arthritis (JIA) RegistryCompletedNCT00783510
- Fecal Biomarker Study for Patients With Ulcerative ColitisCompletedNCT00780507
- Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or RisedronateCompletedNCT00778154
- Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of RisedronateCompletedNCT00755872Phase 1
- Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One PatientCompletedNCT00752596Phase 2
- Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older VolunteersCompletedNCT00752141Phase 1
- Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)CompletedNCT00751738Phase 3
- Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy VolunteersCompletedNCT00751699Phase 1
- Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869CompletedNCT00733187Phase 1
- A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid TumorsCompletedNCT00721669Phase 1
- A Phase 1 Study of ABT-869 in Subjects With Solid TumorsCompletedNCT00718380Phase 1
- Food Effects on the Relative Bioavailability of Different Dosages of RisedronateCompletedNCT00717145Phase 1
- Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00716534Phase 2
- Safety, Efficacy of Pylera BID Dosing in Eradication of H. PyloriWithdrawnNCT00712413Phase 3
- Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00710580Phase 3
- Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal CancerCompletedNCT00707889Phase 2
- Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy SubjectsCompletedNCT00699777Phase 1
- Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected SubjectsCompletedNCT00696904Phase 1
- Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00691964Phase 3
- Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00686933Phase 2
- A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT00679731Phase 3